Arjo AB Class B ( (ARRJF) ) has released its Q4 earnings. Here is a breakdown of the information Arjo AB Class B presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Arjo AB Class B is a leading company in the medical technology sector, specializing in products and systems for patient handling, hygiene, disinfection, and other healthcare-related solutions. It operates primarily in the healthcare and medical devices industry, with a focus on improving patient care and operational efficiency in healthcare settings.
In its latest earnings report for the fourth quarter of 2024, Arjo AB Class B reported a modest increase in net sales to SEK 2,989 million, marking an organic growth of 3.1%. The company achieved an adjusted EBITDA growth of 6.5%, reaching SEK 653 million, and proposed a dividend increase to SEK 0.95 per share. Key developments include the launch of the Symbliss bathing system and a management change with Niclas Sjöswärd appointed as interim President & CEO.
The earnings report highlights a solid financial performance, with an adjusted operating profit increase of 9.7% to SEK 375 million. Although the gross margin slightly decreased to 44.7% from the previous year, the company maintained a strong adjusted EBITDA margin at 21.9%. Sales growth was particularly strong in North America, especially the US, which has emerged as a significant growth driver. Despite some challenges in Europe, Arjo’s service and rental segments continued to perform well.
Looking ahead, Arjo expects organic sales growth for 2025 to align with its target range of 3–5%. The company remains focused on profitability improvements, supported by ongoing initiatives in supply chain efficiency and cost management. Arjo is poised to leverage its solid foundation and strategic developments to capitalize on growth opportunities in key markets, such as the US, Canada, and the UK.
